Literature DB >> 15233376

Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor.

Andrea Levi1, Gian-Luca Ferri, Elizabeth Watson, Roberta Possenti, Stephen R J Salton.   

Abstract

1. The vgf gene encodes a neuropeptide precursor with a restricted pattern of expression that is limited to a subset of neurons in the central and peripheral nervous systems and to specific populations of endocrine cells in the adenohypophysis, adrenal medulla, gastrointestinal tract, and pancreas. In responsive neurons, vgf transcription is upregulated by neurotrophins. the basis for the original identification of VGF as nerve growth factor- (NGF) inducible in PC12 cells (A. Levi, J. D. Eldridge, and B. M. Paterson, Science 229:393-395, 1985). 2. In this review, we shall summarize data concerning the transcriptional regulation of vgf in vitro, the structural organization of the vgf promoter as well as the transcription factors which regulate its activity. 3. On the basis of in situ hybridization and immunohistochemical studies, the in vivo tissue-specific expression of VGF during differentiation and in the adult will be summarized. 4. Parallel biochemical data will be reviewed, addressing the proteolytical processing of the pro-VGF precursor within the secretory compartment of neuroendocrine cells. 5. Finally, analysis of the phenotype of VGF knockout mice will be discussed, implying a nonredundant role of VGF products in the regulation of energy storage and expenditure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233376     DOI: 10.1023/b:cemn.0000023627.79947.22

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  60 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Nucleotide sequence and regulatory studies of VGF, a nervous system-specific mRNA that is rapidly and relatively selectively induced by nerve growth factor.

Authors:  S R Salton
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

3.  Expression of VGF mRNA in the adult rat central nervous system.

Authors:  S E Snyder; S R Salton
Journal:  J Comp Neurol       Date:  1998-04-27       Impact factor: 3.215

4.  A developmentally regulated nerve growth factor-induced gene, VGF, is expressed in geniculocortical afferents during synaptogenesis.

Authors:  A Lombardo; S A Rabacchi; F Cremisi; T Pizzorusso; M C Cenni; R Possenti; G Barsacchi; L Maffei
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

6.  Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells.

Authors:  R Possenti; A M Rinaldi; G L Ferri; P Borboni; E Trani; A Levi
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

7.  Activation of PPARgamma coactivator-1 through transcription factor docking.

Authors:  P Puigserver; G Adelmant; Z Wu; M Fan; J Xu; B O'Malley; B M Spiegelman
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

8.  Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins.

Authors:  M Stark; O Danielsson; W J Griffiths; H Jörnvall; J Johansson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-25

9.  Hypothalamic expression of a novel gene product, VGF: immunocytochemical analysis.

Authors:  A N van den Pol; C Decavel; A Levi; B Paterson
Journal:  J Neurosci       Date:  1989-12       Impact factor: 6.167

10.  Hypothalamic actions of neuromedin U.

Authors:  A M Wren; C J Small; C R Abbott; P H Jethwa; A R Kennedy; K G Murphy; S A Stanley; A N Zollner; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

View more
  64 in total

1.  Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis.

Authors:  Stefan Busse; Hans-Gert Bernstein; Mandy Busse; Hendrik Bielau; Ralf Brisch; Christian Mawrin; Susan Müller; Zoltán Sarnyai; Tomasz Gos; Bernhard Bogerts; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-14       Impact factor: 5.270

2.  Trk retrograde signaling requires persistent, Pincher-directed endosomes.

Authors:  Polyxeni Philippidou; Gregorio Valdez; Wendy Akmentin; William J Bowers; Howard J Federoff; Simon Halegoua
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Identification of tyrosine-nitrated proteins in HT22 hippocampal cells during glutamate-induced oxidative stress.

Authors:  S-W Yoon; S Kang; S-E Ryu; H Poo
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

4.  Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases.

Authors:  Cristina Cocco; Filomena D'Amato; Barbara Noli; Antonella Ledda; Carla Brancia; Paolo Bongioanni; Gian-Luca Ferri
Journal:  J Anat       Date:  2010-10-12       Impact factor: 2.610

5.  Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.

Authors:  Xiuxing Wang; Briana C Prager; Qiulian Wu; Leo J Y Kim; Ryan C Gimple; Yu Shi; Kailin Yang; Andrew R Morton; Wenchao Zhou; Zhe Zhu; Elisabeth Anne Adanma Obara; Tyler E Miller; Anne Song; Sisi Lai; Christopher G Hubert; Xun Jin; Zhi Huang; Xiaoguang Fang; Deobrat Dixit; Weiwei Tao; Kui Zhai; Cong Chen; Zhen Dong; Guoxin Zhang; Stephen M Dombrowski; Petra Hamerlik; Stephen C Mack; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2018-04-05       Impact factor: 24.633

6.  Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry.

Authors:  Ji Eun Lee; Norman Atkins; Nathan G Hatcher; Leonid Zamdborg; Martha U Gillette; Jonathan V Sweedler; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2009-11-10       Impact factor: 5.911

7.  Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.

Authors:  Maureen S Riedl; Patrick D Braun; Kelley F Kitto; Samuel A Roiko; Lorraine B Anderson; Christopher N Honda; Carolyn A Fairbanks; Lucy Vulchanova
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

8.  Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometry.

Authors:  Kazuki Sasaki; Tsukasa Osaki; Naoto Minamino
Journal:  Mol Cell Proteomics       Date:  2012-12-18       Impact factor: 5.911

9.  Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1.

Authors:  Adriana Ramos; Carmen Rodríguez-Seoane; Isaac Rosa; Svenja V Trossbach; Alfredo Ortega-Alonso; Liisa Tomppo; Jesper Ekelund; Juha Veijola; Marjo-Riitta Järvelin; Jana Alonso; Sonia Veiga; Akira Sawa; William Hennah; Angel García; Carsten Korth; Jesús R Requena
Journal:  Hum Mol Genet       Date:  2014-06-16       Impact factor: 6.150

Review 10.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.